Quick Answer
BIO-TECHNE Corp reported Cash And Cash Equivalents At Carrying Value of $162.19 million for the year ending 2025.
- BIO-TECHNE Corp showed an increase of +6.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from BIO-TECHNE Corp's annual report (Form 10-K), filed with the SEC on August 22, 2025.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2009: $195.55 million | Q1 2010: $108.24 million | Q3 2010: $115.01 million | Q4 2010: $135.88 million | Q1 2011: $158.63 million | Q3 2011: $79.24 million | Q4 2011: $80.99 million | Q1 2012: $95.28 million | Q3 2012: $130.81 million | Q4 2012: $143.29 million | Q1 2013: $150.71 million | Q3 2013: $83.86 million | Q4 2013: $98.40 million | Q1 2014: $123.60 million | Q3 2014: $98.24 million | Q4 2014: $92.97 million | Q1 2015: $106.45 million | Q3 2015: $48.84 million | Q4 2015: $64.24 million | Q1 2016: $65.71 million | Q3 2016: $69.59 million | Q4 2016: $58.94 million | Q1 2017: $59.84 million | Q3 2017: $72.46 million | Q4 2017: $121.46 million | Q1 2018: $86.61 million | Q2 2018: $121.99 million | Q3 2018: $94.67 million | Q4 2018: $85.89 million | Q1 2019: $95.56 million | Q3 2019: $99.89 million | Q4 2019: $110.29 million | Q1 2020: $156.22 million | Q3 2020: $169.40 million | Q4 2020: $165.53 million | Q1 2021: $186.14 million | Q3 2021: $196.32 million | Q4 2021: $211.85 million | Q1 2022: $160.82 million | Q3 2022: $165.26 million | Q4 2022: $164.68 million | Q1 2023: $127.28 million | Q3 2023: $148.66 million | Q4 2023: $130.13 million | Q1 2024: $139.92 million | Q3 2024: $187.54 million | Q4 2024: $177.55 million | Q1 2025: $140.67 million | Q2 2025: $162.19 million | Q3 2025: $144.96 million | Q4 2025: $172.88 million.
- Over the full 18 years of available data (2008 to 2025), BIO-TECHNE Corp's Cash And Cash Equivalents At Carrying Value has declined by 2.9%.
- Historical annual values: Fiscal year 2025: $162.19 million | Fiscal year 2024: $151.79 million | Fiscal year 2023: $180.57 million | Fiscal year 2022: $172.57 million | Fiscal year 2021: $199.09 million | Fiscal year 2020: $146.63 million | Fiscal year 2019: $100.89 million | Fiscal year 2018: $121.99 million | Fiscal year 2017: $91.61 million | Fiscal year 2016: $64.24 million | Fiscal year 2015: $54.53 million | Fiscal year 2014: $318.57 million | Fiscal year 2013: $163.79 million | Fiscal year 2012: $116.68 million | Fiscal year 2011: $77.61 million | Fiscal year 2010: $94.14 million | Fiscal year 2009: $160.94 million | Fiscal year 2008: $166.99 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: